Prot#AP24534-10-201: A Pivotal Phase 2 Trial of Ponatinib (AP24534) in Patients with Refractory Chronic Myeloid Leukemia and Ph+Acute Lymphoblastic Leukemia

Project: Research project

Project Details

StatusFinished
Effective start/end date1/31/111/31/17

Funding

  • ARIAD Pharmaceuticals, Inc. (AP24534-10-201)